O'Reilly, T., & McSheehy, P. M. (2010). Biomarker Development for the Clinical Activity of the mTOR Inhibitor Everolimus (RAD001): Processes, Limitations, and Further Proposals. Neoplasia Press Inc.
Styl ChicagoO'Reilly, Terence, a Paul MJ McSheehy. Biomarker Development for the Clinical Activity of the MTOR Inhibitor Everolimus (RAD001): Processes, Limitations, and Further Proposals. Neoplasia Press Inc, 2010.
Citace podle MLAO'Reilly, Terence, a Paul MJ McSheehy. Biomarker Development for the Clinical Activity of the MTOR Inhibitor Everolimus (RAD001): Processes, Limitations, and Further Proposals. Neoplasia Press Inc, 2010.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..